Member LoginDividend CushionValue Trap |
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for
any changes.
May 26, 2017
Alexion’s Executive Departures and an Update from Regeneron Pharma
Image shown above: Performance of Regeneron since the summer of 2013.An executive scandal continues to mar the performance of Alexion Pharmaceuticals. The CFO has resigned his position effective the end of August, but there is more to this story. Let’s also talk Regeneron. Apr 26, 2017
S&P 500 Poised to Make New Highs…Again?
The equity markets have welcomed a strong earnings season thus far, but valuation risk and tail uncertainties remain, not the least of which is the possibility of failed tax reform in the US. Jan 25, 2017
Crisis In Wall Street Stock Research; The Solution? Independent Investment Research
Image Source: Sam Valadi. The dot-com bubble showed how conflicts of interests can sometimes “muddy” the waters when it comes to getting a fair and unbiased opinion on a stock from a Wall Street analyst. Today, a new conflict of interest is brewing. The Wall Street Journal recently reported that sometimes “analysts say ‘buy’ to win special access for their clients” with top executives. Bloomberg followed up the Journal’s article with one of its own. Let’s examine what’s going on. Dec 29, 2016
5 Shocking Stock Market Predictions for 2017
Image Source: Claudia Dea. Valuentum: 2017 Is the Year of Evangeline Adams. Dec 23, 2016
Words Cannot Express How I Feel
Image: Another day at the office. Words cannot express how I feel. Dec 22, 2016
The Next Industrial Revolution - Internet of Things
Image source: Skyworks. The Internet of Things (IoT) is widely recognized as the next major technological adaptation that will transform the building blocks of our lives. Dec 20, 2016
Valuentum’s Dividend Growth Portfolio Retirement Model
Let’s walk through how to use the Valuentum Dividend Growth Portfolio Retirement Model. Oct 31, 2016
Dividend Increases/Decreases for the Week Ending October 28
Let's take a look at companies raising/lowering their dividends this week. Oct 26, 2016
Commodity Price Pressures Dinging Industrial Bellwether Expectations
GE, 3M, and Caterpillar have all reduced their expectations for full-year 2016 results as a result of a challenging operating environment.
prev12345678910111213141516171819202122232425
26272829303132333435363738394041424344454647484950 51525354555657585960616263646566676869707172737475 767778798081828384858687888990919293949596979899100 101102103104105106107108109110111112113114115116117118119120 121122123124125126127128129130next The High Yield Dividend Newsletter, Best Ideas
Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on
this website are for information purposes only and should not be considered a solicitation to buy or sell any
security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s
accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or
omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts
no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a
registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees,
and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.
|
|||||||||||||||||||||
Image Source: Loxo Oncology. The field of oncology remains an area of intense focus with a dire need for new novel therapies. Loxo Oncology generated lots of excitement with the release of its clinical data for Larotrectinib, a TRK-inhibitor for the treatment of a diverse number of tumors.